To the Editor: In the final, 10-year outcomes of the CheckMate 067 trial reported by Wolchok et al. (Jan. 2 issue), 1 the combination of nivolumab and ipilimumab resulted in an unprecedented ...
SAN FRANCISCO -- Post-surgical adjuvant nivolumab (Opdivo) improved survival outcomes in muscle-invasive bladder cancer (MIBC), regardless of the use of neoadjuvant chemotherapy, according to ...
There were 11 hypersensitivity reactions, all in patients receiving nivolumab. Reducing the infusion time for nivolumab and pembrolizumab to 10 minutes is feasible and safe, according to researchers.
In an interview with Targeted Oncology, David Zhen, MD, a medical oncologist and associate professor in the clinical research division at the Fred Hutchinson Cancer Center and associate professor in ...
Manchester United's mascot, Fred the Red has a song and movement routine to help students learn the 6 times table. The 7 Times Table with Moonbeam. videoThe 7 Times Table with Moonbeam The ...
Correspondence to Professor Susumu Kusunoki, Department of Neurology, Kindai University Faculty of Medicine, 377+2 Ohno+Higashi, Osaka+Sayama, Osaka, 589+8511 Japan; kusunoki-tky{at}umin.ac.jp ...
Panelists discuss how the role of systemic therapy in intermediate-stage hepatocellular carcinoma (HCC) is evolving with combinations like immunotherapy and targeted agents enhancing locoregional ...
This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license. This work is licensed under a Creative Commons Attribution 4.0 International ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results